TNYA · Tenaya Therapeutics, Inc.
Market Cap
$154.74M
Shares
224.23M
Tenaya Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Tenaya Therapeutics, Inc. (TNYA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Conference
Investor event
2026-06-04
Tenaya Therapeutics, Inc. (TNYA) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-15
Tenaya Therapeutics, Inc. (TNYA) Q1 2026 Earnings Call
Revenue
$225,000
Diluted EPS
$-0.09
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q3
2025-11-10
Tenaya Therapeutics, Inc. (TNYA) Q3 2025 Earnings Call
Diluted EPS
$-0.12
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-26
Tenaya Therapeutics, Inc. (TNYA) Q2 2025 Earnings Call
Revenue
$
Diluted EPS
$-0.14
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Tenaya Therapeutics, Inc. (TNYA) Q1 2025 Earnings Call
Revenue
$
Diluted EPS
$-0.24
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts
CIK
1858848
CUSIP
87990A106
13F (30d)
80 filings
80 filers
Visit website
Investor relations